AWS
CORT icon

AJ Wealth Strategies’s Corcept Therapeutics CORT Stock Holding History

AJ Wealth Strategies’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$11.3M Hold
509,934
– – 0.55% 36
2023
Q1 		$11M Hold
509,934
– – 0.58% 32
2022
Q4 		$10.4M Hold
509,934
– – 0.54% 32
2022
Q3 		$13.1M Hold
509,934
– – 0.76% 24
2022
Q2 		$12.1M Buy
509,934
+113,905
+29% +$2.48M 0.64% 24
2022
Q1 		$8.92M Hold
396,029
– – 0.44% 35
2021
Q4 		$7.84M Hold
396,029
– – 0.37% 37
2021
Q3 		$7.79M Hold
396,029
– – 0.42% 35
2021
Q2 		$8.71M Sell
396,029
-270,653
-41% -$6.02M 0.52% 23
2021
Q1 		$15.9M Buy
666,682
+270,653
+68% +$7.23M 1.13% 14
2020
Q4 		$10.4M Hold
396,029
– – 0.9% 16
2020
Q3 		$6.89M Sell
396,029
-271,991
-41% -$4.33M 0.7% 22
2020
Q2 		$11.2M Hold
668,020
– – 1.25% 14
2020
Q1 		$7.94M Buy
668,020
+72,192
+12% +$893K 1.08% 13
2019
Q4 		$7.21M Hold
595,828
– – 0.84% 22
2019
Q3 		$8.42M Hold
595,828
– – 1.11% 18
2019
Q2 		$6.64M Sell
595,828
-6
-0% -$67 0.98% 19
2019
Q1 		$7M Buy
595,834
+83,665
+16% +$1.04M 1.16% 18
2018
Q4 		$6.84M Sell
512,169
-2,134
-0.4% -$28.2K 1.32% 18
2018
Q3 		$7.21M Buy
514,303
+73,200
+17% +$1.02M 1.33% 14
2018
Q2 		$6.93M Buy
441,103
+234,483
+113% +$4.08M 1.43% 14
2018
Q1 		$3.4M Buy
206,620
+70,500
+52% +$1.31M 0.81% 19
2017
Q4 		$2.46M Buy
136,120
+4,012
+3% +$72.7K 0.61% 23
2017
Q3 		$2.55M Sell
132,108
-2,083
-2% -$31.1K 0.83% 17
2017
Q2 		$1.58M Buy
134,191
+2,171
+2% +$23.6K 0.6% 25
2017
Q1 		$1.45M Buy
132,020
+15,596
+13% +$137K 0.63% 31
2016
Q4 		$845K Buy
+116,424
New +$912K 0.44% 41

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

AJ Wealth Strategies's CORT Position: Q2 2023 in Review

AJ Wealth Strategies held its Corcept Therapeutics (CORT) position steady in Q2 2023 at 509,934 shares worth $11.3M. The position accounts for 0.55% of the portfolio, ranked #36.

AJ Wealth Strategies first reported a position in CORT in Q4 2016 and has held it in 27 quarters since. The position peaked at $15.9M in Q1 2021. 224 funds tracked by Wall St. Rank hold CORT as of Q2 2023.

  • AJ Wealth Strategies held 509,934 shares of Corcept Therapeutics worth $11.3M as of Q2 2023.
  • AJ Wealth Strategies left its Corcept Therapeutics share count unchanged in Q2 2023.
  • Corcept Therapeutics made up 0.55% of AJ Wealth Strategies's portfolio in Q2 2023, its #36 holding.
  • AJ Wealth Strategies first reported a position in Corcept Therapeutics in Q4 2016 and has held it in 27 quarters since.
  • AJ Wealth Strategies's Corcept Therapeutics position peaked at $15.9M in Q1 2021.
  • 224 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2023.

Based on AJ Wealth Strategies's 13F filing for Q2 2023, filed 20 Jul 2023.